Major peptide autoepitopes for nucleosome-centered T and B cell interaction in human and murine lupus

被引:55
作者
Datta, SK [1 ]
机构
[1] Northwestern Univ, Sch Med, Div Rheumatol, Chicago, IL 60611 USA
来源
IMMUNE MECHANISMS AND DISEASE | 2003年 / 987卷
关键词
systemic lupus erythematosus; autoimmunity; T cell-B cell interaction; anti-DNA autoantibody; tolerance therapy; peptide epitopes; nucleosomes; apoptosis; CD40; ligand;
D O I
10.1111/j.1749-6632.2003.tb06035.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The potential cross-reactivity of normal T and B cells to nuclear antigens is vast, probably due to their "education" by apoptotic cell antigens in generative lymphoid organs. Despite this "nucleocentric repertoire," as we call it, the peripheral immune system normally remains tolerant or ignorant of the products of apoptosis. However, the T helper (Th) cells, and also B cells of lupus, have a regulatory defect in the expression of CD40 ligand (CD40L). A sustained hyper-expression of CD40L by lupus T cells can be triggered by subthreshold stimuli, and is associated with impaired phosphorylation of Cbl-b, a critical downregulatory molecule in T cell signal transduction. This CD40L hyper-expression abnormally prolongs co-stimulatory signals to autoimmune B cells, and it probably instigates APC (dendritic cells, resting anti-DNA B cells, and macrophages) to present apoptotic cell autoantigens in an immunogenic fashion. We have identified the dominant nucleosomal epitopes that are critical for cognate interactions between autoimmune Th cells and anti-DNA B cells in lupus. By scanning of overlapping synthetic peptides, and by mass spectrometry of naturally processed peptides, five major epitopes in nucleosomal histories were localized, namely H1'(22-42), H2B10-33, H3(85-105), H4(16-39), and H4(71-94). The autoimmune T cells as well as B cells of lupus recognize these epitopes, and with age, autoantibodies against the peptide epitopes cross-react with nuclear autoantigens. Moreover, the peptide autoepitopes can be promiscuously presented and recognized by lupus T cells in the context of diverse MHC alleles. This cross-reactivity opens up the possibility of developing "universally" tolerogenic peptides for therapy of lupus in humans despite their MHC diversity. Indeed, tolerogenic therapy with a single histone peptide epitope can halt the progression of established glomerulonephritis in lupus-prone mice by "tolerance spreading" that inactivates a broad spectrum of autoimmune T and B cells in concert.
引用
收藏
页码:79 / 90
页数:12
相关论文
共 80 条
[1]   JUNCTIONAL REGION SEQUENCES OF T-CELL RECEPTOR BETA-CHAIN GENES EXPRESSED BY PATHOGENIC ANTI-DNA AUTOANTIBODY-INDUCING HELPER T-CELLS FROM LUPUS MICE - POSSIBLE SELECTION BY CATIONIC AUTOANTIGENS [J].
ADAMS, S ;
LEBLANC, P ;
DATTA, SK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11271-11275
[2]  
ANDO DG, 1987, J IMMUNOL, V138, P3185
[3]  
Andreassen K, 1999, ARTHRITIS RHEUM, V42, P2449, DOI 10.1002/1529-0131(199911)42:11<2449::AID-ANR24>3.0.CO
[4]  
2-P
[5]   Are there unique autoantigens triggering autoimmune diseases? [J].
Bach, JF ;
Koutouzov, S ;
van Endert, PM .
IMMUNOLOGICAL REVIEWS, 1998, 164 :139-155
[6]   Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b [J].
Bachmaier, K ;
Krawczyk, C ;
Kozieradzki, I ;
Kong, YY ;
Sasaki, T ;
Oliveira-dos-Santos, A ;
Mariathasan, S ;
Bouchard, D ;
Wakeham, A ;
Itie, A ;
Le, J ;
Ohashi, PS ;
Sarosi, I ;
Nishina, H ;
Lipkowitz, S ;
Penninger, JM .
NATURE, 2000, 403 (6766) :211-216
[7]   Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice [J].
Balomenos, D ;
Rumold, R ;
Theofilopoulos, AN .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :364-371
[8]   Lupus nephritis - Discussion [J].
Berden, JHM ;
Madias, NE ;
Broumand, B ;
Klinger, M ;
Sonkodi, S ;
Nayak, KS ;
Hruby, Z .
KIDNEY INTERNATIONAL, 1997, 52 (02) :538-558
[9]   Direct ex vivo analysis of activated, fas-sensitive autoreactive T cells in human autoimmune disease [J].
Bieganowska, KD ;
Ausubel, LJ ;
Modabber, Y ;
Slovik, E ;
Messersmith, W ;
Hafler, DA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (09) :1585-1594
[10]  
Blossom S, 1999, CLIN EXP IMMUNOL, V118, P147